Trilogy 100 Ventilator
by Respironics Inc., Sleep & Home Respiratory Group
510(k) K083526
Active
Valid until
No expiry
FDA recalls
3 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK083526 | Date13 Mar 2009 | StatusActive |
Recalls
-
- Ongoing Z-0882-2023
- Ongoing Z-0884-2023
The replacement silicone sound abatement foam installed into some Trilogy 100 and Trilogy 200 devices may separate from the plastic backing to which it is attached. If this were to happen, the foam could potentially block air inlet, which could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm.
-
- Ongoing Z-1956-2021
The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.
-
- Terminated Z-1065-2016
Software Issue
-
- Terminated Z-1143-2014
Internal testing revealed a potentially defective component on the power management board that could affect the function of certain Trilogy Ventilators resulting in loss of therapy to patients.
-
- Terminated Z-2024-2012
The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.
-
- Terminated Z-0296-2012
Trilogy 100, 200 and 202 units are being recalled due to low impeller press-force used during the manufacturing process. If the press force were low enough, theoretically the impeller could move up the shaft and come into contact with the inside of the blower housing/impeller enclosure. This may impact therapy.
-
- Terminated Z-1896-2010
It is possible that the battery could electrically short, resulting in a potential for fire or a thermal event.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CBK
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.5895
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Other devices from Respironics Inc., Sleep & Home Respiratory Group
See all devices from Respironics Inc., Sleep & Home Respiratory Group →